These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24288042)

  • 21. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
    Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
    Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation.
    Romero-López C; Berzal-Herranz A
    Cell Mol Life Sci; 2012 Jan; 69(1):103-13. PubMed ID: 21598019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules.
    Marton S; Reyes-Darias JA; Sánchez-Luque FJ; Romero-López C; Berzal-Herranz A
    Molecules; 2010 Jun; 15(7):4610-38. PubMed ID: 20657381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome.
    Romero-López C; Berzal-Herranz A
    RNA; 2009 Sep; 15(9):1740-52. PubMed ID: 19605533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of hepatitis C virus replication and internal ribosome entry site-dependent translation by an RNA molecule.
    Romero-López C; Díaz-González R; Barroso-delJesus A; Berzal-Herranz A
    J Gen Virol; 2009 Jul; 90(Pt 7):1659-1669. PubMed ID: 19264618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of RNA aptamers specific for the 3' X tail of HCV.
    Fukuda K; Toyokawa Y; Kikuchi K; Konno K; Ishihara R; Fukazawa C; Nishikawa S; Hasegawa T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):205-6. PubMed ID: 18776325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B.
    Diviney S; Tuplin A; Struthers M; Armstrong V; Elliott RM; Simmonds P; Evans DJ
    J Virol; 2008 Sep; 82(18):9008-22. PubMed ID: 18614633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U).
    You S; Rice CM
    J Virol; 2008 Jan; 82(1):184-95. PubMed ID: 17942554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hepatitis C virus internal ribosome entry site-mediated translation by an RNA targeting the conserved IIIf domain.
    Romero-López C; Díaz-González R; Berzal-Herranz A
    Cell Mol Life Sci; 2007 Nov; 64(22):2994-3006. PubMed ID: 17938858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quasispecies and its impact on viral hepatitis.
    Domingo E; Gomez J
    Virus Res; 2007 Aug; 127(2):131-50. PubMed ID: 17349710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication.
    Kolb G; Reigadas S; Castanotto D; Faure A; Ventura M; Rossi JJ; Toulmé JJ
    RNA Biol; 2006 Oct; 3(4):150-6. PubMed ID: 17299271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targets and tools: recent advances in the development of anti-HCV nucleic acids.
    Romero-López C; Sánchez-Luque FJ; Berzal-Herranz A
    Infect Disord Drug Targets; 2006 Jun; 6(2):121-45. PubMed ID: 16789875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatitis C virus replication by pol III-directed overexpression of RNA decoys corresponding to stem-loop structures in the NS5B coding region.
    Zhang J; Yamada O; Sakamoto T; Yoshida H; Araki H; Murata T; Shimotohno K
    Virology; 2005 Nov; 342(2):276-85. PubMed ID: 16139319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.
    Kikuchi K; Umehara T; Fukuda K; Kuno A; Hasegawa T; Nishikawa S
    Nucleic Acids Res; 2005; 33(2):683-92. PubMed ID: 15681618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication.
    Friebe P; Boudet J; Simorre JP; Bartenschlager R
    J Virol; 2005 Jan; 79(1):380-92. PubMed ID: 15596831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cis-acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome.
    Lee H; Shin H; Wimmer E; Paul AV
    J Virol; 2004 Oct; 78(20):10865-77. PubMed ID: 15452207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.
    You S; Stump DD; Branch AD; Rice CM
    J Virol; 2004 Feb; 78(3):1352-66. PubMed ID: 14722290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral hepatitis C.
    Poynard T; Yuen MF; Ratziu V; Lai CL
    Lancet; 2003 Dec; 362(9401):2095-100. PubMed ID: 14697814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.